BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31518336)

  • 1. A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer.
    Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Smailyte G
    Aging (Albany NY); 2019 Sep; 11(17):7197-7205. PubMed ID: 31518336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cohort Study of Antihyperglycemic Medication and Pancreatic Cancer Patients Survival.
    Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Smailyte G
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32824907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of metformin on survival in patients with melanoma-national cohort study.
    Urbonas V; Rutenberge J; Patasius A; Dulskas A; Burokiene N; Smailyte G
    Ann Epidemiol; 2020 Dec; 52():23-25. PubMed ID: 32980534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preexisting diabetes, metformin use and long-term survival in patients with prostate cancer.
    Linkeviciute-Ulinskiene D; Patasius A; Kincius M; Zabuliene L; Smailyte G
    Scand J Urol; 2020 Oct; 54(5):401-407. PubMed ID: 32748714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin increases cancer specific survival in colorectal cancer patients-National cohort study.
    Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Urbonas V; Smailyte G
    Cancer Epidemiol; 2019 Oct; 62():101587. PubMed ID: 31491730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cohort Study of Exposure to Antihyperglycemic Therapy and Survival in Patients with Lung Cancer.
    Danila E; Linkevičiūtė-Ulinskienė D; Zablockis R; Gruslys V; Cicėnas S; Smailytė G
    Int J Environ Res Public Health; 2020 Mar; 17(5):. PubMed ID: 32156062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study.
    Kim YI; Kim SY; Cho SJ; Park JH; Choi IJ; Lee YJ; Lee EK; Kook MC; Kim CG; Ryu KW; Kim YW
    Aliment Pharmacol Ther; 2014 Apr; 39(8):854-63. PubMed ID: 24612291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes Medication Use in Association with Survival among Patients of Breast, Colorectal, Lung, or Gastric Cancer.
    Baglia ML; Cui Y; Zheng T; Yang G; Li H; You M; Xu L; Murff H; Gao YT; Zheng W; Xiang YB; Shu XO
    Cancer Res Treat; 2019 Apr; 51(2):538-546. PubMed ID: 29986576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: national cohort study.
    Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Urbonas V; Smailyte G
    Eur J Cancer Prev; 2020 Jul; 29(4):289-293. PubMed ID: 31567536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cohort Study of Antihyperglycemic Medication Exposure and Gastric Cancer Risk.
    Dulskas A; Patasius A; Kaceniene A; Linkeviciute-Ulinskiene D; Zabuliene L; Smailyte G
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32033451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database.
    Taussky D; Preisser F; Karakiewicz PI; Tilki D; Lambert C; Bahary JP; Delouya G; Wistaff R; Laskine M; Nguyen PV; Durand M; Saad F
    Can J Urol; 2018 Oct; 25(5):9509-9515. PubMed ID: 30281009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy.
    Lee CK; Jung M; Jung I; Heo SJ; Jeong YH; An JY; Kim HI; Cheong JH; Hyung WJ; Noh SH; Kim HS; Rha SY; Chung HC
    Ann Surg; 2016 Jan; 263(1):96-102. PubMed ID: 25575260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort study.
    Lee DJ; McMullen CP; Foreman A; Huang SH; Lu L; Xu W; de Almeida JR; Liu G; Bratman SV; Goldstein DP
    J Otolaryngol Head Neck Surg; 2019 Jul; 48(1):34. PubMed ID: 31345259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of metformin on gastric adenocarcinoma survival: A Belgian population based study.
    Lacroix O; Couttenier A; Vaes E; Cardwell CR; De Schutter H; Robert A
    Cancer Epidemiol; 2018 Apr; 53():149-155. PubMed ID: 29453032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis.
    Shuai Y; Li C; Zhou X
    Clin Transl Oncol; 2020 Sep; 22(9):1580-1590. PubMed ID: 32060719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy.
    Inzucchi SE; Tunceli K; Qiu Y; Rajpathak S; Brodovicz KG; Engel SS; Mavros P; Radican L; Brudi P; Li Z; Fan CP; Hanna B; Tang J; Blonde L
    Diabetes Obes Metab; 2015 Oct; 17(10):956-64. PubMed ID: 25962401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
    Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
    Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
    Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?
    Lemon LS; Orr B; Modugno F; Buckanovich RJ; Coffman L; Edwards RP; Taylor S
    Gynecol Oncol; 2022 Apr; 165(1):60-66. PubMed ID: 35140015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.
    Tseng CH
    Aging (Albany NY); 2016 Aug; 8(8):1636-49. PubMed ID: 27587088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.